Skip to main content

Table 1 Association between pre- and post-chemotherapy fibrinogen levels and clinical characteristics

From: Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen

Characteristics

 

pre-chemotherapy fibrinogen

pre-chemotherapy fibrinogen

 

N (%)

(g/L) (mean ± SD)

p value

(g/L) (mean ± SD)

p value

Age

     

<60

95(59.4 %)

4.58 ± 1.28

0.053

4.44 ± 1.27

0.018

≥60

65(40.6 %)

5.06 ± 1.65

 

4.79 ± 1.27

 

gender

     

Male

102(63.8 %)

4.91 ± 1.53

0.041

4.72 ± 1.21

0.023

Female

58(36.2 %)

4.40 ± 1.29

 

4.34 ± 1.25

 

Stage

     

III

60(37.5 %)

4.895 ± 1.68

0.497

4.61 ± 1.35

0.851

IV

100(62.5 %)

4.639 ± 1.32

 

4.57 ± 1.24

 

Histological type

     

Adenocarcinoma

98(61.2 %)

4.69 ± 1.41

0.358

4.60 ± 1.28

0.677

Squamous carcinoma

34(21.3 %)

5.06 ± 1.72

 

4.36 ± 1.16

 

Others

28(17.5 %)

4.41 ± 1.28

 

4.78 ± 1.39

 

ECOG

     

0

105(65.6 %)

4.55 ± 1.38

0.051

4.33 ± 1.11

0.002

1

55(34.4 %)

5.04 ± 1.57

 

5.07 ± 1.44

Â